![Hardman & Co](https://directorstalk.net/wp-content/uploads/2018/10/hardman-Co.png)
Shield Therapeutics: PBMs have bought in to Accrufer
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following the US launch